| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/06/2013 | CN103381268A Solid pharmaceutical composition including proton pump inhibitor |
| 11/06/2013 | CN103381267A Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 11/06/2013 | CN103381227A External liniment and internal traditional Chinese medicine preparation formula for alopecia treatment |
| 11/06/2013 | CN103381217A Six-flavor hematinic capsule, its quality control method and application thereof |
| 11/06/2013 | CN103381191A Sugar-free laggera herba mixture and preparation method thereof |
| 11/06/2013 | CN103381149A Venlafaxine hydrochloride single-chamber osmotic pump controlled release tablet and preparation method thereof |
| 11/06/2013 | CN103381148A Solid preparation including finasteride and preparation method thereof |
| 11/06/2013 | CN103381147A Film-coating method for traditional Chinese medicine sustained-and-controlled release preparation |
| 11/06/2013 | CN103381146A Double-layer sustained and controlled release nanoparticle and preparation method thereof and application |
| 11/06/2013 | CN103381145A Method for improving levodropropizine taste by solid dispersion |
| 11/06/2013 | CN103381144A Preparation method of vitamin E succinate-modified doxorubicin liposome |
| 11/06/2013 | CN103381141A Praziquantel long-circulating nanoparticle injection and preparation method thereof |
| 11/06/2013 | CN103381140A Inosine-common salt composition and preparation method thereof |
| 11/06/2013 | CN103381139A In situ gel for astragalus polysaccharide injection and preparation method thereof |
| 11/06/2013 | CN103381138A Statin oral self-microemulsifying release preparation and preparation method thereof |
| 11/06/2013 | CN103127007B Sodium glycididazole composition and preparation method thereof |
| 11/06/2013 | CN103110933B Elcatonin composition and preparation method thereof |
| 11/06/2013 | CN102871951B Hyaluronic acid nano microgel loaded with anti-cancer medicine and preparation method for hyaluronic acid nano microgel |
| 11/06/2013 | CN102793730B Ginkgo-damole medicinal composition and preparation method thereof |
| 11/06/2013 | CN102772367B Preparation method of targeting composite nanoparticle |
| 11/06/2013 | CN102727431B Injecta containing milrinone and preparation method thereof |
| 11/06/2013 | CN102669679B Method for preparing chrysanthemum morifolium ramat extract in microwave-assisted way |
| 11/06/2013 | CN102657787B Compound lonicera and forsythia ammonia-sensitive capsules and preparation technology thereof |
| 11/06/2013 | CN102614239B Silymarin compound nanoparticle and preparation method thereof |
| 11/06/2013 | CN102597030B Implantable bio-resorbable polymer |
| 11/06/2013 | CN102596253B Mucoadhesive polymers having vitamin B substructures |
| 11/06/2013 | CN102585015B Fusion protein containing glicetin-1 as well as preparation method and application |
| 11/06/2013 | CN102580109B Anti-cancer drug carrier and method for producing same |
| 11/06/2013 | CN102579337B Long circulation lipid nano-suspension containing docetaxel and preparation method thereof |
| 11/06/2013 | CN102573813B 持续药物传递系统 Sustained drug delivery system |
| 11/06/2013 | CN102552950B Production process of unstable chemical injection |
| 11/06/2013 | CN102552906B Productive technology of intravenous injection human immunoglobulin |
| 11/06/2013 | CN102552289B Composition for treating diabetes and preparation method |
| 11/06/2013 | CN102526743B Coating material for complex tablets and preparation method thereof |
| 11/06/2013 | CN102525927B Octreotide acetate preparation and preparation method thereof |
| 11/06/2013 | CN102504015B Cardiovascular targeted small peptide MI-1 and application thereof |
| 11/06/2013 | CN102440951B Azasetron hydrochloride injection and preparation method thereof |
| 11/06/2013 | CN102430147B Biodegradable strontium-doped calcium sulfate material having biological activity, and its preparation method and use |
| 11/06/2013 | CN102421451B Bendamustine cyclopolysaccharide compositions |
| 11/06/2013 | CN102399295B Low-sulfhydrylation-modification-degree biocompatible high-molecular sulfhydrylation derivatives, cross-linking material thereof, and purpose thereof |
| 11/06/2013 | CN102391377B Fusion protein capable of inducing and activating cancer targeting T-cells as well as preparation method and application of the fusion protein |
| 11/06/2013 | CN102357087B Metoprolol fumarate sustained-release tablet and preparation method thereof |
| 11/06/2013 | CN102348458B Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 11/06/2013 | CN102336802B Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method |
| 11/06/2013 | CN102295778B Hyperbranched polyphosphoramidate and preparation method thereof |
| 11/06/2013 | CN102196810B Pharmaceutical composition improved in absorption through intestinal tract |
| 11/06/2013 | CN102085193B Tibolone orally disintegrating tablets and method for preparing same |
| 11/06/2013 | CN102083413B Method and composition for treating ocular hypertension and glaucoma |
| 11/06/2013 | CN102066402B Peptide derivative and composition for promoting tear secretion comprising the same |
| 11/06/2013 | CN102018962B Polymer intensifier in controlled release preparation |
| 11/06/2013 | CN101909651B External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 11/06/2013 | CN101801359B Transdermal delivery devices assuring an improved release of an active principle through a biological interface |
| 11/06/2013 | CN101798586B Process for producing glycopeptides |
| 11/06/2013 | CN101490087B Antibodies and immunoconjugates and uses therefor |
| 11/06/2013 | CN101394753B Method for improving affinity of sparingly soluble or insoluble substance in solvent using water-soluble xylan |
| 11/06/2013 | CN101361723B Improved pharmaceutical compositions |
| 11/06/2013 | CN101134038B 缓释的口服给药组合物 The sustained-release composition for oral administration |
| 11/05/2013 | US8575332 Crosslinked polysaccharide microparticles and method for their preparation |
| 11/05/2013 | US8575223 Cream for applying on a body |
| 11/05/2013 | US8575147 Spontaneously dispersible N-benzoyl staurosporine compositions |
| 11/05/2013 | US8575142 Agent for improving insulin resistance |
| 11/05/2013 | US8575137 Composition for inhalation |
| 11/05/2013 | US8575092 Gelling hydrophobic injectable polymer compositions |
| 11/05/2013 | US8574634 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
| 11/05/2013 | US8574624 Highly inhibited starch fillers for films and capsules |
| 11/05/2013 | US8574619 Reducing cholesterol levels with combined use of quercetin and statin |
| 11/05/2013 | US8574590 Lipoparticles comprising proteins, methods of making, and using the same |
| 11/05/2013 | US8574568 Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s) |
| 11/05/2013 | CA2762911C Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation |
| 11/05/2013 | CA2752865C Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent |
| 11/05/2013 | CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 11/05/2013 | CA2550718C Cohesive gels from cross-linked hyaluronan and/or hylan, their preparation and use |
| 11/05/2013 | CA2492803C Oxime conjugates and methods for their formation and use |
| 10/31/2013 | WO2013163407A1 Silk microspheres and methods for surface lubrication |
| 10/31/2013 | WO2013163321A1 Singlet oxygen-labile linkers and methods of production and use thereof |
| 10/31/2013 | WO2013162771A1 Lectin conjugates for mucin hydration |
| 10/31/2013 | WO2013162757A1 Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use |
| 10/31/2013 | WO2013162723A1 Topical formulation compositions containing silicone based excipients to deliver actives to a substrate |
| 10/31/2013 | WO2013162413A1 Pharmaceutical composition of an s1p receptor agonist for treating demyelinated disorders (alternatives) and method for producing same |
| 10/31/2013 | WO2013162114A1 Sustained-release preparation using gastroretentive drug delivery system |
| 10/31/2013 | WO2013162054A1 Composition for controlling chromatin structure |
| 10/31/2013 | WO2013162048A1 Injectable preparation |
| 10/31/2013 | WO2013162041A1 Unit structure-type pharmaceutical composition for nucleic acid delivery |
| 10/31/2013 | WO2013161994A1 Analgesic |
| 10/31/2013 | WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same |
| 10/31/2013 | WO2013161896A1 Sustained release carrier for drugs |
| 10/31/2013 | WO2013161895A1 Bone repair promoter |
| 10/31/2013 | WO2013161830A1 Injectable formulation |
| 10/31/2013 | WO2013161823A1 Orally disintegrating tablet and method for producing same |
| 10/31/2013 | WO2013161815A1 Tablet containing glutamic acid and arginine at high contents |
| 10/31/2013 | WO2013161805A1 Method for producing starch granules, and orally disintegrating tablet |
| 10/31/2013 | WO2013161778A1 Method for producing an aqueous dispersion of drug nanoparticles and use thereof |
| 10/31/2013 | WO2013161751A1 Composite particles and cell preparation prepared using same |
| 10/31/2013 | WO2013161103A1 Composition having titanium oxide prevented from colour change |
| 10/31/2013 | WO2013161098A1 Polymer particles, method for producing same, and use therefor |
| 10/31/2013 | WO2013160885A1 A nanosphere - histone acetyltransferase (hat) activator composition, process and methods thereof |
| 10/31/2013 | WO2013160807A1 A method for antigen delivery |
| 10/31/2013 | WO2013160340A1 Prodrugs of hydroxyl-comprising drugs |
| 10/31/2013 | WO2013159411A1 Ginkgolide injection and preparation method thereof |
| 10/31/2013 | WO2013159185A1 Porphyrin-lipid stabilized nanoparticles for surface enhanced raman scattering based imaging |